FOCALFLEX (CE Mark) Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

March 30, 2026

Conditions
Atrial Fibrillation Paroxysmal
Interventions
DEVICE

TactiFlex™ Ablation Catheter Sensor Enabled™

Pulsed field ablation (PFA)/radiofrequency (RF) ablation with the TactiFlex™ Ablation Catheter Sensor Enabled™

Trial Locations (24)

1090

UZ Brussel, Brussels

2145

Westmead Hospital, Westmead

3050

Royal Melbourne Hospital - City Campus, Parkville

3910

Peninsula Private Hospital, Langwarrin

4020

A. ö. Krankenhaus der Elisabethinen Linz, Linz

5000

Royal Adelaide Hospital, Adelaide

8036

Universitätsklinik Graz, Graz

8200

Skejby University Hospital, Aarhus

20132

Ospedale San Raffaele, Milan

20138

Centro Cardiologico Monzino, Milan

28034

Hospital Ramón y Cajal, Madrid

31008

Clínica Universidad de Navarra, Pamplona

32545

Herz-und Diabetes Zentrum NRW, Bad Oeynhausen

33604

Hopital Haut Leveque, Pessac

37001

Nemocnice Ceske Budejovice, a.s., České Budějovice

37170

CHU Trousseau, Chambray-lès-Tours

46026

Hospital Universitari i Politècnic La Fe, Valencia

75651

Hôpital Pitié Salpetrière, Paris

80636

Deutsches Herzzentrum München des Freistaates Bayern, München

9713 GZ

Universitair Medische Centrum Groningen, Groningen

3435 CM

St. Antonius Ziekenhuis, Nieuwegein

2333 ZA

Leiden University Medical Center, Leiden

2545AA

Haga Ziekenhuis Locatie Leyenburg, The Hague

BN25BE

The Royal Sussex County Hospital, Brighton

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY